Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Fulcrum Therapeutics (FULC) Restructuring Costs (2022 - 2024)

Historic Restructuring Costs for Fulcrum Therapeutics (FULC) over the last 2 years, with Q3 2024 value amounting to $2.1 million.

  • Fulcrum Therapeutics' Restructuring Costs changed N/A to $2.1 million in Q3 2024 from the same period last year, while for Sep 2025 it was $2.1 million, marking a year-over-year increase of 187.65%. This contributed to the annual value of $2.1 million for FY2024, which is N/A changed from last year.
  • Per Fulcrum Therapeutics' latest filing, its Restructuring Costs stood at $2.1 million for Q3 2024.
  • In the past 5 years, Fulcrum Therapeutics' Restructuring Costs registered a high of $2.1 million during Q3 2024, and its lowest value of -$38000.0 during Q4 2022.